
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
The changing fundamentals of the industry are causing Big Pharma to focus more on operating efficiency instead of just product performance.
over 22 years ago
Hyperthermophilic Microorganisms and USP Hot Water Systemsover 22 years ago
Electronic Information Systemsover 22 years ago
CMO-grown Innovation and Technologyover 22 years ago
Segregation of Powders during Gravity Flow Through Vertical Pipes